Free Trial

GH Research (GHRS) Financials

GH Research logo
$22.44 +1.16 (+5.45%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$23.00 +0.56 (+2.47%)
As of 07:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for GH Research

Annual Income Statements for GH Research

This table shows GH Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-0.31 -0.45 -9.20 -22 -36 -39 -48
Consolidated Net Income / (Loss)
-0.31 -0.45 -9.20 -22 -36 -39 -48
Net Income / (Loss) Continuing Operations
-0.31 -0.45 -9.20 -22 -36 -39 -48
Total Pre-Tax Income
-0.31 -0.45 -9.20 -22 -36 -39 -48
Total Operating Income
-0.31 -0.45 -15 -31 -41 -50 -61
Total Gross Profit
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
0.31 0.45 15 31 41 50 61
Selling, General & Admin Expense
0.01 0.11 6.55 10 11 15 22
Research & Development Expense
0.30 0.34 8.55 20 30 35 39
Total Other Income / (Expense), net
0.00 0.00 5.90 8.22 5.63 11 12
Interest Expense
- - 0.01 0.12 0.72 0.72 0.46
Interest & Investment Income
- - 0.00 1.17 8.98 9.87 11
Other Income / (Expense), net
0.00 0.00 5.91 7.18 -2.62 2.13 1.75
Income Tax Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share
($0.01) ($0.02) ($0.21) ($0.43) ($0.68) ($0.75) ($0.79)
Weighted Average Basic Shares Outstanding
- - 52.02M 52.02M 52.03M 52.03M 62.03M
Diluted Earnings per Share
($0.01) ($0.02) ($0.21) ($0.43) ($0.68) ($0.75) ($0.79)
Weighted Average Diluted Shares Outstanding
- - 52.02M 52.02M 52.03M 52.03M 62.03M
Weighted Average Basic & Diluted Shares Outstanding
- - 52.02M 52.02M 52.03M 52.03M 62.03M

Quarterly Income Statements for GH Research

No quarterly income statements for GH Research are available.


Annual Cash Flow Statements for GH Research

This table details how cash moves in and out of GH Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
0.51 5.17 271 -111 -88 23 -21
Net Cash From Operating Activities
-0.29 -0.33 -15 -25 -33 22 -48
Net Cash From Continuing Operating Activities
-0.29 -0.33 -15 -25 -26 22 -48
Net Income / (Loss) Continuing Operations
-0.31 -0.45 -9.20 -22 -36 -39 -48
Consolidated Net Income / (Loss)
-0.31 -0.45 -9.20 -22 -36 -39 -48
Depreciation Expense
0.00 0.00 0.02 0.05 0.32 0.32 0.34
Non-Cash Adjustments To Reconcile Net Income
0.02 0.12 -6.09 -3.35 4.91 61 -0.04
Net Cash From Investing Activities
0.00 0.00 -0.10 -85 -54 -0.05 27
Net Cash From Continuing Investing Activities
0.00 0.00 -0.10 -85 -54 -0.05 27
Sale and/or Maturity of Investments
- - - - 0.00 - 27
Net Cash From Financing Activities
0.80 5.50 286 0.00 -0.20 0.00 0.00
Net Cash From Continuing Financing Activities
0.80 5.50 286 0.00 -0.20 0.00 0.00

Quarterly Cash Flow Statements for GH Research

No quarterly cash flow statements for GH Research are available.


Annual Balance Sheets for GH Research

This table presents GH Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
5.91 280 254 226 188 288
Total Current Assets
5.91 280 169 164 154 286
Cash & Equivalents
5.90 277 166 78 101 246
Other Current Assets
0.02 3.07 2.59 2.53 4.90 5.27
Other Current Nonoperating Assets
- - 0.00 56 19 0.00
Plant, Property, & Equipment, net
0.00 0.00 0.10 1.07 0.75 0.62
Plant, Property & Equipment, gross
0.00 - 0.10 1.07 0.75 0.62
Total Noncurrent Assets
0.00 0.08 0.00 0.00 0.00 1.63
Other Noncurrent Operating Assets
- 0.08 - - 0.00 1.63
Total Liabilities & Shareholders' Equity
5.91 280 254 226 188 288
Total Liabilities
0.25 2.75 4.55 7.33 9.32 8.53
Total Current Liabilities
0.25 2.75 4.55 6.70 8.95 8.38
Accounts Payable
0.00 0.88 1.87 3.49 3.74 3.77
Other Current Liabilities
0.25 1.87 2.68 3.21 5.21 4.61
Total Noncurrent Liabilities
0.00 0.00 0.00 0.63 0.37 0.15
Capital Lease Obligations
- - 0.00 0.63 0.37 0.15
Total Equity & Noncontrolling Interests
5.67 277 250 219 179 280
Total Preferred & Common Equity
5.67 277 250 219 179 280
Total Common Equity
5.67 277 250 219 179 280
Common Stock
6.30 1.30 293 293 293 433
Retained Earnings
-0.84 -10 -32 -68 -106 -154
Other Equity Adjustments
0.20 286 -10 -5.86 -7.37 1.52

Quarterly Balance Sheets for GH Research

No quarterly balance sheets for GH Research are available.


Annual Metrics And Ratios for GH Research

This table displays calculated financial ratios and metrics derived from GH Research's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - 62,029,395.00
DEI Adjusted Shares Outstanding
- - - - - - 62,029,395.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - -0.78
Growth Metrics
- - - - - - -
Profitability Metrics
- - - - - - -
Net Operating Profit after Tax (NOPAT)
-0.22 -0.31 -11 -21 -29 -35 -43
Return On Investment Capital (ROIC_SIMPLE)
- - - -8.56% -13.14% -19.64% -15.19%
Earnings before Interest and Taxes (EBIT)
-0.31 -0.45 -9.19 -23 -44 -48 -59
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-0.31 -0.45 -9.17 -23 -43 -48 -59
Valuation Ratios
- - - - - - -
Leverage & Solvency
- - - - - - -
Liquidity Ratios
- - - - - - -
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -0.08 -11 -19 -28 -35 -45
Efficiency Ratios
- - - - - - -
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 -0.23 0.40 -1.86 -3.10 -3.30 -0.86
Increase / (Decrease) in Invested Capital
0.00 -0.23 0.63 -2.26 -1.24 -0.20 2.45
Book Value per Share
$0.00 $0.57 $5.33 $4.80 $4.21 $3.44 $5.38
Tangible Book Value per Share
$0.00 $0.57 $5.33 $4.80 $4.21 $3.44 $5.38
Total Capital
0.00 5.67 277 250 220 179 280
Total Debt
0.00 0.00 0.00 0.00 0.63 0.37 0.15
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.63 0.37 0.15
Net Debt
0.00 -5.90 -277 -166 -78 -100 -246
Capital Expenditures (CapEx)
0.00 0.00 0.10 0.07 0.10 0.05 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -0.23 0.32 -1.96 79 44 31
Debt-free Net Working Capital (DFNWC)
0.00 5.67 277 164 157 145 278
Net Working Capital (NWC)
0.00 5.67 277 164 157 145 278
Net Nonoperating Expense (NNE)
0.09 0.13 -1.37 1.07 6.73 3.74 5.76
Net Nonoperating Obligations (NNO)
0.00 -5.90 -277 -252 -222 -182 -281
Total Depreciation and Amortization (D&A)
0.00 0.00 0.02 0.05 1.04 0.32 0.34
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.21) $0.00 ($0.68) ($0.75) ($0.79)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 52.02M 0.00 52.03M 52.03M 62.03M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.21) $0.00 ($0.68) ($0.75) ($0.79)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 52.02M 0.00 52.03M 52.03M 62.03M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 52.02M 0.00 52.03M 52.03M 62.03M
Normalized Net Operating Profit after Tax (NOPAT)
-0.22 -0.31 -11 -21 -29 -35 -43
Debt Service Ratios
- - - - - - -
Payout Ratios
- - - - - - -

Quarterly Metrics And Ratios for GH Research

No quarterly metrics and ratios for GH Research are available.



Financials Breakdown Chart

Frequently Asked Questions About GH Research's Financials

When does GH Research's fiscal year end?

According to the most recent income statement we have on file, GH Research's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has GH Research's net income changed over the last 6 years?

GH Research's net income appears to be on an upward trend, with a most recent value of -$48.26 million in 2025, rising from -$310 thousand in 2019. The previous period was -$38.96 million in 2024. View GH Research's forecast to see where analysts expect GH Research to go next.

What is GH Research's operating income?
GH Research's total operating income in 2025 was -$60.72 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $60.72 million
How has GH Research's revenue changed over the last 6 years?

Over the last 6 years, GH Research's total revenue changed from $0.00 in 2019 to $0.00 in 2025, a change of 0.0%.

How much debt does GH Research have?

GH Research's total liabilities were at $8.53 million at the end of 2025, a 8.5% decrease from 2024, and a 3,366.3% increase since 2020.

How much cash does GH Research have?

In the past 5 years, GH Research's cash and equivalents has ranged from $5.90 million in 2020 to $276.78 million in 2021, and is currently $246.25 million as of their latest financial filing in 2025.

How has GH Research's book value per share changed over the last 6 years?

Over the last 6 years, GH Research's book value per share changed from 0.00 in 2019 to 5.38 in 2025, a change of 537.6%.



Financial statements for NASDAQ:GHRS last updated on 4/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners